Related Experiment Video
Updated: Jun 16, 2026
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Medulloblastoma in young children.
Stefan Rutkowski1, Bruce Cohen, Jonathan Finlay
1Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. s.rutkowski@uke.de
Pediatric Blood & Cancer
|February 11, 2010
Summary
Different treatment strategies for early childhood medulloblastoma aim to improve survival and avoid craniospinal radiotherapy. High-dose chemotherapy shows promise in multimodal approaches for young children with advanced disease.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Cancer Treatment
Background:
- Medulloblastoma is a common brain tumor in early childhood.
- Craniospinal radiotherapy is a standard treatment but carries significant long-term side effects.
- Current research focuses on treatment strategies to minimize or avoid radiotherapy in young children.
Purpose of the Study:
- To review current treatment strategies for early childhood medulloblastoma.
- To evaluate the role of high-dose chemotherapy in delaying or avoiding craniospinal radiotherapy.
- To highlight the importance of risk-adapted treatment based on clinical and histological factors.
Main Methods:
- Review of current national treatment protocols for pediatric medulloblastoma.
- Analysis of the role of high-dose chemotherapy in multimodal treatment strategies.
- Consideration of clinical and histological prognostic factors, including nodular-desmoplastic variants.
Main Results:
- Three distinct treatment strategies are employed globally.
- High-dose chemotherapy is recognized for its potential to delay or avoid craniospinal radiotherapy.
- Nodular-desmoplastic variants are significant prognostic indicators influencing treatment recommendations.
Conclusions:
- Multimodal treatment strategies, including high-dose chemotherapy, are crucial for managing early childhood medulloblastoma.
- Risk stratification based on prognostic factors enables tailored treatment approaches.
- Minimizing radiotherapy exposure is a key goal in optimizing outcomes for young patients.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...